Cardinal Health Inc (CAH) : Dsc Advisors reduced its stake in Cardinal Health Inc by 0.01% during the most recent quarter end. The investment management company now holds a total of 180,220 shares of Cardinal Health Inc which is valued at $13,038,917 after selling 17 shares in Cardinal Health Inc , the firm said in a disclosure report filed with the SEC on Nov 14, 2016.Cardinal Health Inc makes up approximately 7.97% of Dsc Advisors’s portfolio.
Other Hedge Funds, Including , Assetmark Inc reduced its stake in CAH by selling 110 shares or 16.11% in the most recent quarter. The Hedge Fund company now holds 573 shares of CAH which is valued at $37,342.World Asset Management Inc reduced its stake in CAH by selling 3,516 shares or 8.31% in the most recent quarter. The Hedge Fund company now holds 38,801 shares of CAH which is valued at $2,665,241. Cardinal Health Inc makes up approx 0.10% of World Asset Management Inc’s portfolio.Bangor Savings Bank boosted its stake in CAH in the latest quarter, The investment management firm added 121 additional shares and now holds a total of 3,949 shares of Cardinal Health Inc which is valued at $297,004. Cardinal Health Inc makes up approx 0.07% of Bangor Savings Bank’s portfolio.
Cardinal Health Inc closed down -0.87 points or -1.21% at $70.77 with 26,53,027 shares getting traded on Monday. Post opening the session at $71.53, the shares hit an intraday low of $70.6501 and an intraday high of $71.59 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Cardinal Health Inc reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Oct 31, 2016. Analyst had a consensus of $1.20. The company had revenue of $32039.00 million for the quarter, compared to analysts expectations of $31007.13 million. The company’s revenue was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.38 EPS.
Many Wall Street Analysts have commented on Cardinal Health Inc. Shares were Downgraded by Robert W. Baird on Oct 28, 2016 to ” Neutral” and Lowered the Price Target to $ 82 from a previous price target of $92 .Cardinal Health Inc was Downgraded by Goldman to ” Neutral” on Sep 16, 2016.
Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.